 |
Acute Promyelocytic Leukemia |
|
|
 |
| |
| Acute Promyelocytic Leukemia (APML) also termed as AML-M3, is a variant of acute leukemia (Blood Cancer). It is often associated with serious coagulation abnormalities. Due to its hemorrhagic nature, most of the time, a patient may die during the process of diagnosis itself. Intense and frequent transfusions, hygienic condition and combination of ATRA with chemotherapy bring remission to a fair number of patients. However, more than fifty percent patients of APML experience relapse of the disease and succumb to causality most of the time. There are few cases who can not continue with conventional modern medicines due to hematological or non hematological side effects of the treatment and fall in high mortality group. Similarly, high cost of the treatment and supportive care also lead to high mortality in such cases. |
|
|
| |
|
|
| |
Late Vaidya Chandra Prakash of Meerut treated Master Salman Sherwani (S. no. 1 in MBAT & APML (De novo) - I) for AML-M3 in December 1982. That ten year old boy has now completed twenty five years disease free survival without experiencing any side effects. He lives happily with his children in Dubai. (See table) |
|
| |
|
|
| |
A pilot study on “EFFECT OF METAL BASED AYURVEDIC FORMULATIONS IN THE PATIENTS OF ACUTE PROMYELOCYTIC LEUKEMIA” has been carried under the ages of Department of AYUSH, and sponsored by Central Council of Research in Ayurveda and Siddha (CCRAS), under Ministry of Health and Welfare, Government of India. The patients who completed ninety days ayurvedic treatment showed complete recovery from the APML. Refer monograph |
|
| |
|
|
| |
In lieu of the above findings, National Research Development Corporation (NRDC) has obtained US and European patents against the said invention. At this moment, Ayurvedic treatment for APML is available at Mumbai, Bangalore and Dehradun. For further details, contact us. |
|
| |
|
|
| |
|
|
| |
|
|
|
